Cargando…
Contributions and prognostic performances of m7G RNA regulators in pancreatic adenocarcinoma
Autores principales: | Yuan, Qihang, Ren, Jie, Chen, Xu, Dong, Yantong, Shang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746722/ https://www.ncbi.nlm.nih.gov/pubmed/36201641 http://dx.doi.org/10.1097/CM9.0000000000002179 |
Ejemplares similares
-
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021) -
A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo
por: Wang, Zhizhou, et al.
Publicado: (2023) -
Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis
por: Yao, Yixing, et al.
Publicado: (2023) -
WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021) -
Diagnostic indexes of a rapid immunoglobulin G/immunoglobulin M combined antibody test for severe acute respiratory syndrome coronavirus 2
por: Liu, Ying, et al.
Publicado: (2021)